Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”

Daniel C. Malone (), Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, John Horn, Malinda S. Tan and Richard D. Boyce
Additional contact information
Daniel C. Malone: University of Utah
Lorenzo Villa-Zapata: Mercer University
Ainhoa Gómez-Lumbreras: University of Utah
John Horn: University of Washington
Malinda S. Tan: University of Utah
Richard D. Boyce: University of Pittsburgh

Drug Safety, 2022, vol. 45, issue 12, No 11, 1553-1555

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-022-01239-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:45:y:2022:i:12:d:10.1007_s40264-022-01239-3

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-022-01239-3

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().